Skip to main content

Synagis Disease Interactions

There is 1 disease interaction with Synagis (palivizumab).

Major

Palivizumab (applies to Synagis) platelet disorders

Major Potential Hazard, High plausibility. Applicable conditions: Coagulation Defect, Thrombocytopathy, Thrombocytopenia

Palivizumab is administered by IM injection and the risk of bleeding is increased in the presence of platelet function disorders and/or thrombocytopenia. Therapy with palivizumab should be administered cautiously in patients with coagulation disorders or thrombocytopenia.

References

  1. (2001) "Product Information. Synagis (palivizumab)." Ross Product Division Pharmaceuticals

Synagis drug interactions

There are 3 drug interactions with Synagis (palivizumab).

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer